SCHEMBL13764887

SCHEMBL13764887

COc1ccc(C(Nc2ccc(CN)cc2)[C@@H](CC[C@H](O[Si](C)(C)C(C)(C)C)c2ccc(F)cc2)C(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
MAPK1 P28482 2/20 0.38
POLB P06746 2/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CRHBP P24387 1/20 0.38
CYP2C19 P33261 1/20 0.38
CRHR2 Q13324 1/20 0.38
KLK7 P49862 4/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005382 1.00 LMNA (0.39) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL4005388 1.00 LMNA (0.39) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL3998015 0.93 KMT2A (0.38) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL3998019 0.93 KMT2A (0.38) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL4000662 0.85 NPY5R (0.41) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL3997462 0.83 LMNA (0.43) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL13764901 0.83 LMNA (0.43) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL3997458 0.83 LMNA (0.43) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL3997472 0.83 LMNA (0.45) LMNAGAAMEN1KMT2AMAPK1
SCHEMBL13764883 0.83 LMNA (0.45) LMNAGAAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7563888-B2 Process for the preparation of diphenyl azetidinone derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-07-21 US disclosed
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149501-A1 PROCESS FOR THE PREPARATION OF DIPHENYL AZETIDINONE DERIVATIVES CYP46A1, APOB, DHCR7 LMNA 912/4885GAA 1290/4885MEN1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.